The HPV vaccine does not treat existing infections
the verdict
SUPPORTED
the evidence backs this
confidence 84/100
Standard prophylactic HPV vaccines prevent new infections but do not treat existing ones, which has spurred research into distinct therapeutic vaccines.
Evidence for · 5
Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy
2021 · cited by 31
Prophylactic human papillomavirus vaccines are commercially available for prevention but are not able to combat pre-existing infections.
See more details
More for · 4
Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach
2015 · cited by 17
Prophylactic vaccines have no therapeutic effect on existing lesions or infections.
A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses
2025 · cited by 4
As prophylactic HPV vaccines cannot eliminate existing infections, developing therapeutic vaccines is critical.
Intranasal Delivery of HPV Therapeutic Vaccines for Enhanced Mucosal Immunization and Anti-Tumor Immunity.
2025 · cited by 2
Currently approved HPV vaccines are prophylactic and show no significant therapeutic effect on pre-existing infections or lesions.
Designing a novel therapeutic candidate vaccine for HPV16 using immunoinformatics approach: Targeting E6 and E7 epitopes with TLR4 agonist integration.
2026 · cited by 0
Although prophylactic vaccinations for human papillomaviruses have been approved, these vaccines lack therapeutic efficacy and cannot eradicate pre-existing infections.